bioRN News and not to miss Autumns Highlights 2024

*|MC:SUBJECT|*

bioRN News October 2024

Dear *|FNAME|* *|LNAME|*,

You will have recognised it straight away: we have a new design and are proud to present our new look in the newsletter for the first time.
In addition we have also relaunched our homepage: Our aim was to develop a clear and user-friendly website that provides you with the latest information from our life science ecosystem. You can watch the video clip describing our transition here.
Do you like what you see? Please feel free to send your feedback to comms@biorn.org.

We celebrated our new branding at the bioRN Annual Conference, which took place as part of the bioRN Life Science Week.
Flashback bioRN life science week 2024: A wave of enthusiastic feedback is still reaching us!
From October 8th– 10th the life science region Rhine-Neckar was a magnet for scientists, industry representatives and investors, who experienced excellent research from the region, promising innovations in the field of personalised medicine and pitches from startups in the biotech, medtech and digital health sectors. Starting with the premiere of the Industry-Academia-Day, an exclusive event for bioRN pharma partners on October 8th, the bioRN Annual Conference opened its doors October 9th in the Heidelberg Congress Center to almost 500 registered attendees celebrating the highlight event of the year under the topic ‘New Therapeutic Modalities in Personalised Medicine’.
October 10th, the Life Science Week ended with a Life Science Investors’ Day which more than fulfilled the expectations of the registered 90 investors from all over Europe.
All information about the Life Science Week 2024 and the bioRN Annual Conference can be found on our brand new website.

Join us last-minute today
1) at 12pm with M2M featuring WMT AG
join the next ‘M2M – Member to member session’ to meet WMT AG, a company founded by two brilliant minds who focused on finding a new approach to block the Warburg effect and eventually developed synthetic small molecules that effectively trigger the Integrated Stress Response (ISR).
Register here and dial in: https://us02web.zoom.us/meeting/register/tZAofumvrTsrGdKF4Uh0ImDQilUSkBWvgXHI

2) at 7pm at the bioRN-Lounge featuring Novaliq in the Urban Kitchen Heidelberg:
Our guest speaker is Christian Roesky, CEO at Novaliq talking about: "From Innovation to Market Development: Insights into the magic of Novaliq's EyeSol®Technology".
Register here:

Bio Europe from November 4th -6th in Stockholm - meet us at the German Pavilion!
We are exhibiting at the German Pavilion and look forward to meet you there!

Enjoy more news from our network and take a look at the calls at 04I Innovation Promotion

We wish you a wonderful golden autumn!
Kind regards

Stephanie Füller
PR Manager
bioRN Life Science Cluster

01 | Research Highlights & News

DKFZ:

Stronger together: miniature robots in convoy for endoscopic surgery [more]
Critical Pathway for rare brain tumor discovered [more]
Language model “UroBot“ surpasses the accuracy of experienced urologists [more]

DKFZ & EMBL: How do rare genetic variants affect health? AI provides more accurate predictions [more]

EMBL: What we can learn from hungry yeast cells [more]

NMI - Natural and Medical Sciences Institute: Startup immuneAdvice wins Young Scientists Pitch Competition [more]

Promega develops new enzyme to significantly reduce stutter artifacts in forensic DNA analysis [more]

Heidelberg University & UKHD - Heidelberg University Hospital:

Life Sciences Bridge Award for Dr Vivek Thacker [more]
Fewer side effects from proton beam therapy [more]

YUMAB and MOLCURE Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets [more]

02 | New Members

!LEVA specializes in guiding pharmaceutical companies through the complexities of development, from company foundation to early clinical studies. Over the past 25 years, the !LEVA management team has co-founded and successfully managed nearly a dozen companies, mainly in the pharmaceutical sector, while supporting numerous biotech companies in corporate and product development. !LEVA Sciences was founded to share this expertise with innovative life science projects, helping companies achieve success through hands-on involvement and C-level leadership when needed.

Daiichi Sankyo’s European roots date back to the 1980s with branches in Düsseldorf. In 1990, Sankyo acquired Luitpold-Werke, a German pharmaceutical company, expanding operations to Pfaffenhofen, Germany, and Altkirch, France. In 2006, Daiichi and Sankyo merged, with European headquarters in Munich. Now present in 13 countries, Daiichi Sankyo employs over 2,000 people, making it one of Europe’s largest Japanese pharmaceutical companies. It develops and markets treatments for hypertension, dyslipidemia, infections, cardiovascular diseases, and thrombotic disorders.

iQMedix aims to improve the lives of cancer patients by providing personalized treatments based on molecular analysis. Using liquid biopsies to determine gene expression profiles from circulating tumor cells, iQMedix enables doctors to tailor therapies to each patient's unique cancer. Their approach offers precise insights to determine effective treatments. Their vision is to make cancer a manageable disease through personalized therapies, bringing hope and a cure to every patient by using advanced biotechnology to fully understand and outsmart cancer.

OLS - OMNI Life Science accelerates cell research with smart, reliable, and user-friendly technologies for life sciences and biotechnology. Their products are used in public, private, pharmaceutical, and biotech labs. The portfolio includes instruments, media, reagents, consumables, and services for Cell Counting, Culture, Imaging, Flow Cytometry, and Analysis. OLS supports researchers throughout the entire process, from conception to conclusion. They also offer instrument maintenance and provide training courses through their Life Science School.

Pitchload's goal is to make innovation ecosystems more transparent, accessible, and efficient. Startups and accelerators currently waste time maintaining databases and creating PDFs. Pitchload’s mission is to create a "single source of truth" for the European innovation ecosystem, starting locally but aiming globally. Pitchload offers streamlined information sharing, syncing with third-party systems, and privacy control for startups.

The platform connects two groups:
- Innovators (incubators, accelerators, hubs) 🚀
- Those seeking innovation (corporates, SMEs, investors) 🔍

SPT Labtech transforms the way scientists work by pioneering automation in liquid handling, sample preparation, and management for over 25 years. Their solutions streamline lab tasks, reduce human error, and ensure precise, consistent results. Using positive displacement technology, they enable ultra-low volume accuracy, saving reagents and samples. Their automated systems simplify sample storage and organization, while their cryo-EM tools enhance structural biology research. Headquartered in Melbourn, UK, with 400+ employees, SPT operates globally across the US, UK, Germany, and China.

03 | Event Spotlights

04 | Event Calendar & Discounts

Deep Tech Venture Builder Programme Call 2025
Call applications close 16 December 2024. >>

Self-Paced Course: Molecular Biology Techniques 2024
Oktober 21 - December 01, 2024 - Online >>

M2M – Member to Member session featuring WMT AG
Oktober 29, 2024 - Online via Zoom >>

bioRN Lounge featuring Christian Roesky – Novaliq
Oktober 29, 2024 - Heidelberg >>

BIO-Europe® 2024
November 04-06, 2024 - Stockholm, Sweden
November 12–13, 2024 - Digital Partnering >>
BioRN Members receive a 15 % discount.

Webinar: Advancing medicinal chemistry with high-throughput low-volume liquid handling
November 05, 2024 - Online >>

Trinational HealthTech Days #5
November 07-08, 2024 - Breisach am Rhein >>

Innovation and Equity in Health Tech: A Start-up and Investor Summit:
Connect and Celebrate the Future of Innovation
November 18, German Cancer Research Center Communication Center Heidelberg >>

Safe the date: ordinary Member´s assembly and evening reception of BioRN Network e.V:
November 28 at 5pm: Business Development Center, Carl Friedrich Gauß Ring 5, 69124 Heidelberg

BioFIT 2024 - Fostering Innovation & Transfer
December 03-04, 2024 - Lille, France & Online >>
BioRN Members receive a 20 % discount.

German Biotechnology Days 2025
April09-10, 2025 - Heidelberg, Germany >>
BioRN is the regional host!

05 | Innovation Promotion

In this section we provide selected information on funding calls and events:

Canadian Delegation visits Heidelberg B2B:  November 8th
Biologics have revolutionized the treatment of many conditions and continue to be a major focus of research and development in the medical field. Don’t miss this chance to meet with some of Canada’s most advanced companies and join the BioRN B2B platform to check new business opportunities!
[more]

Introducing Redalpine Capital VII (RAC VII): Redalpine closes a new record fund of over €179 million
[more]

Atomico announces largest ever fundraise, totalling $1.24 billion to support Europe’s most ambitious founders
[more ]

Headline raises $865m growth fund — and is eyeing defence and pharma startups
[more]

Private insurers are setting up new venture capital funds for e-health start-ups
[more ]

Fresh Capital: The following 3 Funds were closed:
Eir Partners Closes $496M Investment Program II  [more]
Vsquared closes second fund of €214m to cash in on Europe’s deeptech boom  [more]
HTGF Opportunity Fund launches with 660 million euros for the growth phase  [more]

06 | Open Positions

BioRN Network e.V.:

Team Mitglied (m/w/d): Office Manager [more]

Heidelberg Pharma AG:

(Senior) Animal Care Taker (m/w/d) [more]
Biologielaborant Abteilung In Vivo Biologie (m/w/d) in Vollzeit oder vollzeitnaher Teilzeit (min. 30 Std./Woche) [more]

PEPperPRINT GmbH:

Chemielaborant/in, CTA (m/w/d) [more]
Scientist with a biomedical background as Freelance France Business Development Manager (m/f/d) [more]

Forward

Imprint